Ruggie Capital Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-140
Closed -$4K 220
2019
Q2
$4K Buy
+140
New +$3.46K 0.01% 178
2019
Q1
Sell
-10
Closed 357
2018
Q4
$0 Hold
10
﹤0.01% 513
2018
Q3
$0 Buy
+10
New +$244 ﹤0.01% 286
2018
Q1
Sell
-10
Closed 320
2017
Q4
$0 Hold
10
﹤0.01% 326
2017
Q3
$0 Hold
10
﹤0.01% 271
2017
Q2
$0 Hold
10
﹤0.01% 299
2017
Q1
$0 Hold
10
﹤0.01% 266
2016
Q4
$0 Hold
10
﹤0.01% 176
2016
Q3
$0 Hold
10
﹤0.01% 207
2016
Q2
$0 Hold
10
﹤0.01% 221
2016
Q1
$0 Buy
+10
New +$268 ﹤0.01% 175
2015
Q4
Sell
-10
Closed 118
2015
Q3
$0 Buy
+10
New +$283 ﹤0.01% 286

Other funds holding NVO

Ruggie Capital Group's NVO Position: Q3 2019 in Review

Ruggie Capital Group sold out of Novo Nordisk (NVO) in Q3 2019, closing a stake of 140 shares — an estimated $4K sold.

Ruggie Capital Group first reported a position in NVO in Q3 2015 and held it in 12 quarters. The position peaked at $4K in Q2 2019. 564 funds tracked by Wall St. Rank hold NVO as of Q3 2019.

  • Ruggie Capital Group reported no remaining Novo Nordisk position as of Q3 2019 after selling out during the quarter.
  • Ruggie Capital Group sold 140 Novo Nordisk shares in Q3 2019, an estimated $4K.
  • Ruggie Capital Group first reported a position in Novo Nordisk in Q3 2015 and held it in 12 quarters.
  • Ruggie Capital Group's Novo Nordisk position peaked at $4K in Q2 2019.
  • 564 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2019.

Based on Ruggie Capital Group's 13F filing for Q3 2019, filed 6 Nov 2019.